Pediatrix Medical Group, Inc. (NYSE:MD) Stock Has Average Target Price of $28.00 According to Analysts

Key Points

• Analysts have a consensus “Hold” rating on Pediatrix Medical Group: five of seven analysts rate it Hold, while one rates it Sell and one Buy. Their average 12-month price target is $28.
• The stock traded at $31.35, above the average analyst target, after reaching a 12-month high of $33.74.
• Pediatrix beat quarterly estimates, reporting EPS of $0.72 versus $0.65 expected and revenue of $501.37 million versus $498.18 million expected; revenue rose 1.7% year over year.

Shares of Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) have earned a consensus recommendation of "Hold" from the seven research firms that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $28.00.

A number of brokerages recently issued reports on MD. Wall Street Zen upgraded Pediatrix Medical Group from a "buy" rating to a "strong-buy" rating in a report on Sunday, September 13th. Truist Financial boosted their target price on Pediatrix Medical Group from $28.00 to $31.00 and gave the stock a "hold" rating in a research report on Friday, October 30th. Mizuho downgraded Pediatrix Medical Group from a "neutral" rating to an "underperform" rating and set a $28.00 target price for the company. in a report on Wednesday. Jefferies Financial Group lowered Pediatrix Medical Group from a "buy" rating to a "hold" rating and increased their price target for the company from $27.00 to $28.00 in a research report on Wednesday, August 19th. Finally, Weiss Ratings upgraded Pediatrix Medical Group from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Wednesday, September 9th.

Institutional Trading of Pediatrix Medical Group

Hedge funds have recently bought and sold shares of the company. BlackRock Inc. acquired a new position in shares of Pediatrix Medical Group in the second quarter worth about $347,383,000. Dimensional Fund Advisors LP raised its holdings in shares of Pediatrix Medical Group by 8.1% during the first quarter. Dimensional Fund Advisors LP now owns 3,856,915 shares of the company's stock valued at $82,496,000 after acquiring an additional 287,696 shares during the period. Wasatch Advisors LP lifted its position in shares of Pediatrix Medical Group by 21.9% in the 2nd quarter. Wasatch Advisors LP now owns 2,498,884 shares of the company's stock valued at $63,297,000 after acquiring an additional 448,360 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its position in shares of Pediatrix Medical Group by 27.9% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,070,961 shares of the company's stock valued at $53,348,000 after acquiring an additional 452,051 shares in the last quarter. Finally, Renaissance Technologies LLC lifted its position in shares of Pediatrix Medical Group by 12.9% in the 1st quarter. Renaissance Technologies LLC now owns 1,532,300 shares of the company's stock valued at $32,776,000 after acquiring an additional 174,600 shares in the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Price Performance

NYSE:MD traded down $0.05 during trading hours on Friday, reaching $31.35. 468,051 shares of the company's stock were exchanged, compared to its average volume of 747,847. The company has a market capitalization of $2.45 billion, a P/E ratio of 17.04 and a beta of 0.62. Pediatrix Medical Group has a 12 month low of $17.23 and a 12 month high of $33.74. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 0.47. The business's 50-day simple moving average is $27.88 and its two-hundred day simple moving average is $24.34.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings results on Thursday, October 29th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.65 by $0.07. The company had revenue of $501.37 million for the quarter, compared to analysts' expectations of $498.18 million. Pediatrix Medical Group had a return on equity of 20.12% and a net margin of 7.66%. The firm's revenue was up 1.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.67 earnings per share. Sell-side analysts expect that Pediatrix Medical Group will post 2.23 EPS for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group provides physician services to hospitals and other healthcare facilities across the United States. Its clinicians care for women, newborns and children, working with healthcare partners to support patients in hospital and other clinical settings. The company's services include neonatal care, maternal-fetal medicine and pediatric subspecialties. Its physicians and advanced practice providers deliver care such as treatment for high-risk pregnancies and specialized medical services for newborns and children.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.